Brett Monia, CEO Level 15, Director at Ionis Pharmaceuticals, holds 174.29K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 6.00K shares in Cognition Therapeutics (Ticker: CGTX).

See the Hottest Stocks Based on Insider Trading >

Brett Monia
Ionis Pharmaceuticals (IONS)
CEO Level 15, Director

Ranked #18,119 out of 98,624 Corporate Insiders

Profitable Transactions

5 out of 6 Profitable Transactions

Average Return

+13.40%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

99.84%

IONS

0.16%

CGTX

A breakdown of Brett Monia's holdings

See the Top Stocks by Insiders

Insider Roles

Ionis Pharmaceuticals
(IONS)

CEO Level 15, Director

Cognition Therapeutics
(CGTX)

Director

Roles that Brett Monia holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Ionis Pharmaceuticals
(IONS)

Rating:Informative Buy

Date:Aug 29, 2018 - Aug 29, 2019

Return:+38.70%

The most profitable trade made by Brett Monia

See the Latest Stocks Traded by Insiders

Brett Monia's Trading History

IONS

Ionis Pharmaceuticals

Mar 04, 2024

CEO Level 15, Director

Uninformative Buy

18.52K

$7.25M

CGTX

Cognition Therapeutics

Jun 13, 2023

Director

Uninformative Buy

―

$11.70K

List of latest transactions for each holding click on a transaction to see Brett Monia's performance on stock

See All Insider Trading from Today

Brett Monia insider profile FAQ

What is the percentage of profitable transactions made by Brett Monia?

The percentage of profitable transactions made by Brett Monia is 83%.

What is the average return per transaction made by Brett Monia?

The average return per transaction made by Brett Monia is 13.40%.

What stocks does Brett Monia hold?

Brett Monia holds: IONS, CGTX stocks.

What was Brett Monia’s latest transaction?

Brett Monia latest transaction was an Uninformative Buy of $18.52K.

What was Brett Monia's most profitable transaction?

Brett Monia’s most profitable transaction was an Informative Buy of IONS stock on August 29, 2018. The return on the trade was 38.70%.

What is Brett Monia's role in Ionis Pharmaceuticals?

Brett Monia's role in Ionis Pharmaceuticals is CEO Level 15, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Brett Monia Insider Profile

Brett Monia Ionis Pharmaceuticals (IONS)CEO Level 15, Director